rs1923834
From SNPedia
Orientation | plus |
Stabilized | plus |
Make rs1923834(C;C) |
Make rs1923834(C;T) |
Make rs1923834(T;T) |
Reference | GRCh38 38.1/141 |
Chromosome | 13 |
Position | 27786350 |
is a | snp |
is | mentioned by |
dbSNP | rs1923834 |
dbSNP (classic) | rs1923834 |
ClinGen | rs1923834 |
ebi | rs1923834 |
HLI | rs1923834 |
Exac | rs1923834 |
Gnomad | rs1923834 |
Varsome | rs1923834 |
LitVar | rs1923834 |
Map | rs1923834 |
PheGenI | rs1923834 |
Biobank | rs1923834 |
1000 genomes | rs1923834 |
hgdp | rs1923834 |
ensembl | rs1923834 |
geneview | rs1923834 |
scholar | rs1923834 |
rs1923834 | |
pharmgkb | rs1923834 |
gwascentral | rs1923834 |
openSNP | rs1923834 |
23andMe | rs1923834 |
SNPshot | rs1923834 |
SNPdbe | rs1923834 |
MSV3d | rs1923834 |
GWAS Ctlg | rs1923834 |
GMAF | 0.1038 |
Max Magnitude | 0 |
? | (C;C) (C;T) (T;T) | 28 |
---|---|---|
|
GWAS snp | |
---|---|
PMID | [PMID 23648065![]() |
Trait | Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin) |
Title | Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan. |
Risk Allele | G |
P-val | 5E-6 |
Odds Ratio | 3.24 [1.823-5.744] |